We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
+$2.43M
(+0.2%)
Cap. Flow
-$7.16M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
24.8%
Holding
309
New
15
Increased
119
Reduced
146
Closed
4
Avg Time Held
4.1
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.1M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$795K |
| 3 |
Kellanova
K
|
+$738K |
| 4 |
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
+$676K |
| 5 |
Vanguard Emerging Markets Government Bond ETF
VWOB
|
+$557K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$5.3M |
| 2 |
CACI
CACI
|
+$2.06M |
| 3 |
Anadarko Petroleum
APC
|
+$1.66M |
| 4 |
Costco
COST
|
+$1.13M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$974K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.99% |
| 2 | Technology | 14.23% |
| 3 | Healthcare | 13.23% |
| 4 | Financials | 11.24% |
| 5 | Consumer Staples | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ADMS
301
DELISTED
Adamas Pharmaceuticals
ADMS
| $66K | 0.01% |
+13,000
| New | +$80.3K |
2019 Q3
0 quarters
|
|
|
VJET
302
Flyte Aviation, Inc.
VJET
$2.05M
| – | – |
0
| – | – |
2019 Q2
1 quarter
|
|
303
Fortress Biotech
FBIO
$63.7M
| $28K | ﹤0.01% |
1,333
| – | – |
2019 Q1
2 quarters
|
|
304
DELISTED
CBL& Associates Properties, Inc.
CBL
| $13K | ﹤0.01% |
+10,000
| New | +$10.4K |
2019 Q3
0 quarters
|
|
305
Actinium Pharmaceuticals
ATNM
$33.3M
| $5K | ﹤0.01% |
762
| – | – |
2015 Q4
15 quarters
|
|
306
DXC Technology
DXC
$2.2B
| – | – |
-3,664
| Closed | -$202K | – |
|
307
DELISTED
Forte Biosciences
FBRX
| – | – |
-46
| Closed | -$114K | – |
|
308
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
| – | – |
-1,854
| Closed | -$206K | – |
|
|
309
DELISTED
Anadarko Petroleum
APC
| – | – |
-23,579
| Closed | -$1.66M | – |
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q3 2019 Portfolio in Review
As of Q3 2019, Dowling & Yahnke held 309 positions worth $1.21B, up 0.2% from $1.21B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Dowling & Yahnke's Q3 2019 filing shows 15 new, 119 increased, 146 reduced and 4 closed positions. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 12,553 shares worth $805K. The largest sale was Raytheon Company, an estimated $5.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
- Dowling & Yahnke's largest Q3 2019 buy was iShares MSCI USA Min Vol Factor ETF: 12,553 shares worth $805K.
- Dowling & Yahnke added most to State Street Energy Select Sector SPDR ETF in Q3 2019, an estimated $1.1M increase.
- Dowling & Yahnke's biggest Q3 2019 reduction was Raytheon Company, cutting an estimated $5.3M.
- Dowling & Yahnke fully exited Anadarko Petroleum in Q3 2019, selling an estimated $1.66M.
- Dowling & Yahnke's ten largest holdings make up 25% of its $1.21B portfolio in Q3 2019.
- Dowling & Yahnke opened 15 new positions and closed 4 in Q3 2019.
- Dowling & Yahnke's portfolio value rose 0.2% quarter-over-quarter to $1.21B.
Based on Dowling & Yahnke's 13F filing for Q3 2019, filed 29 Oct 2019.